Symptoms documented in cases of long COVID are wide ranging and variable.
Sruthi S. Balakrishnan is a freelance science writer based in Bangalore, India. After spending her doctoral days poking fruit flies in the eye, she realized that she preferred writing about science more than doing science. She finished her PhD and made the ol’ pipette-to-pen transition in 2019. She now writes about things such as kleptomaniacal sea slugs and ants that can control their own gut microbes. Follow her on Twitter @sruthisanjeev.
View Full Profile
Learn about our Editorial Policies.
Infection with SARS-CoV-2 can lead to symptoms that last for weeks, months, or even years, and scientists are only just beginning to understand why. The long-term effects of COVID-19 have been reported to affect nearly every organ system. The type, severity, and duration of the symptoms vary across individuals, and researchers still know little about the mechanisms of long COVID.
Read the full story.
Sruthi S. Balakrishnan is a freelance science writer based in Bangalore, India. After spending her doctoral days poking fruit flies in the eye, she realized that she preferred writing about science more than doing science. She finished her PhD and made the ol’ pipette-to-pen transition in 2019. She now writes about things such as kleptomaniacal sea slugs and ants that can control their own gut microbes. Follow her on Twitter @sruthisanjeev.
View Full Profile
The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
Partnership unites AI and single cell technology to map immune dysfunction and improve drug discovery and development outcomes
Designed to balance ease of use, cost efficiency, and reproducible data, which are critical requirements for successful high-throughput screening campaigns
Automated Twist NGS library preparation workflows available on SPT Labtech’s firefly platform via the firefly cloud
